Whole exome sequencing (WES) of metastatic leiomyosarcoma (LMS) and liposarcoma (LPS) and correlation of genomic aberrations with clinical outcomes in the phase III randomized trial of trabectedin (T) vs. dacarbazine (D)
Abstract only
Saved in:
Published in: | Journal of clinical oncology Vol. 36; no. 15_suppl; p. 11513 |
---|---|
Main Authors: | , , , , , , , , , , , , , |
Format: | Journal Article |
Language: | English |
Published: |
20-05-2018
|
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Abstract only |
---|---|
ISSN: | 0732-183X 1527-7755 |
DOI: | 10.1200/JCO.2018.36.15_suppl.11513 |